OWC Pharmaceutical Research Corp. Stock Analysis OWCP
OWC Pharmaceutical Research Corp. engages in the research and development of cannabis-based medical products for the treatment of myeloma and psoriasis. The firm is engaged in the research and development of cannabis-based medical products (the Product Prospects) for the treatment of multiple myeloma, psoriasis and fibromyalgia, as well as development of a cannabis soluble tablet delivery system that has applications for other indications. The firm also provides consulting services to governmental and private entities to assist them with developing and implementing various medical cannabis programs. As of September 30, 2016, the Company was engaged in two business activities: work with GUMI to commercialize and market the Company's Electromagnetic Percussion Device (the Device), and research and development of Cannabis-based medical products for the treatment of a range of medical conditions and/or diseases, such as multiple myeloma, psoriasis, post-traumatic stress disorder (PTSD) migraines and a delivery system.
Read More OWC Pharmaceutical Research Corp (OWCP) Chart
Financial Metrics & Statements of OWC Pharmaceutical Research Corp (OWCP)
FAQ's for OWC Pharmaceutical Research Corp (OWCP)
- According to Musaffa’s Shariah screening methodology, OWC Pharmaceutical Research Corp (OWCP) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.